SELEXYS PHARMACEUTICALS CORPORATION

Basic Information

840 RESEARCH PKWY, STE 516
OKLAHOMA CITY, OK, -

Company Profile

n/a

Additional Details

Field Value
DUNS: 145737131
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Development of an Anti-P-selectin Antibody for the Treatment of Sickle Cell Disea

    Amount: $3,112,914.00

    DESCRIPTION (provided by applicant): Selexys Pharmaceuticals is developing a humanized monoclonal antibody drug called SelG1 directed against P-selectin for the treatment of vasoocclusive crisis in pa ...

    SBIR Phase II 2012 Department of Health and Human Services
  2. Development of an Anti-PSGL-1 Antibody to Treat Crohn's Disease

    Amount: $2,553,342.00

    DESCRIPTION (provided by applicant): The primary objective of this proposal is to develop and commercialize a safe and more effective therapy for the treatment of Crohn's Disease, an inflammatory ...

    SBIR Phase II 2011 Department of Health and Human Services
  3. Development of an Anti-PSGL-1 Antibody to Treat Crohn's Disease

    Amount: $3,113,970.00

    DESCRIPTION (provided by applicant): The primary objective of this proposal is to develop and commercialize a safe and more effective therapy for the treatment of Crohn's Disease, an inflammatory bowe ...

    SBIR Phase I 2010 Department of Health and Human Services
  4. Development of an Anti-P-selectin Antibody for the Treatment of Sickle Cell Disea

    Amount: $3,342,790.00

    DESCRIPTION (provided by applicant): Selexys Pharmaceuticals is developing a humanized monoclonal antibody drug directed against P-selectin for the treatment of vasoocclusive crisis in patients with s ...

    SBIR Phase I 2009 Department of Health and Human Services
  5. PEGylation of a Glycosulfopeptide Anti-Inflammatory

    Amount: $304,843.00

    DESCRIPTION (provided by applicant): Normal recruitment of circulating white blood cells (leukocytes) into tissues is important in inflammation, lymphocyte homing, and immunological responses. The me ...

    SBIR Phase I 2004 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government